Genetic Literacy and Patient-Caregiver Communication of Prognostic Genetic Technology for Localized Prostate Cancer
Project Number5K01CA230193-05
Former Number5K01CA230193-02
Contact PI/Project LeaderCOBRAN, EWAN KEMAR
Awardee OrganizationMAYO CLINIC ARIZONA
Description
Abstract Text
Project Summary/Abstract
Novel genomic technology, such as microarray analyses and next-generation sequencing, have improved the
understanding of prostate cancer biology and prognosis. The National Comprehensive Cancer Network
(NCCN), in 2016, recommended that patients and clinicians consider tissue-based genetic tests for localized
prostate cancer. However, while much enthusiasm currently exits for the rapidly increasing field of genomic
medicine, the use of multi-gene mRNA expression panels raises the potential for further divergence in prostate
cancer treatment outcomes by race and low socioeconomic status. We know that health disparities persist in
low income groups despite the existence of evidence-based guidelines and that adoption of state-of-the-art
methods often lag behind in these groups.
The goals of this NCI K01 application are to (1) explore how men with localized prostate cancer and their
caregivers comprehend prognostic genetic technology, and (2) examine how an educational video about
genetics impacts patient-caregiver communication of prognostic genetic technology. The study rationale is that
without direct attention to genomic comprehension, the enthusiasm that exists in the rapidly increasing field of
prostate cancer genomic medicine may not translate into health benefits for men with localized prostate
cancer. The central hypotheses are (1) men and caregivers with lower levels of education will demonstrate a
severe lack of genomic comprehension of tissue-based genetic tests for localized prostate cancer; and (2)
tailored prostate cancer education, communication coaching, and a genomic literacy educational video will
significantly improve patient-caregiver communication in a low literacy population.
The study approach is innovative because it applies a mixed-methods community-engagement research
framework to explore how African American and rural White men with localized prostate cancer,
comprehend and interpret data generated from genetic technology. The proposed research is significant
because of its potential to improve public health by (1) improving the understanding of prognostic genetics in
minority, low income, and rural populations, and (2) engage and educate these diverse communities about
genomics. The proposed research, in combination with a structured mentoring and training plan that includes
didactic course and workshops, is designed to facilitate Dr. Ewan Cobran’s long term goal of developing an
independently-funded research program in prostate cancer disparities, consistent with the mission of the
NCI.
Public Health Relevance Statement
Project Narrative
With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with to
make better treatment planning decisions. This project is designed to investigate the understanding of
prognostic genetic technology and patient-caregiver communication in African American and rural White men
with localized prostate cancer.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdoptionAdultAfrican AmericanAlabamaAmericanBiochemicalCancer BiologyCancer PrognosisCaregiversCommunicationCommunitiesComprehensionData AnalysesDeath RateDiagnosisDiffusion of InnovationDisadvantagedDisparityEducationEducational StatusEducational workshopEthnic PopulationFocus GroupsFundingGenesGeneticGenomic medicineGenomicsGeographic LocationsGoalsGroup InterviewsHealth BenefitHealth SciencesImpairmentIncidenceInvestmentsKnowledgeLiteratureLouisianaLow Income PopulationLow Literacy PopulationLow incomeMalignant neoplasm of prostateMarylandMentorsMethodsMicroarray AnalysisMinorityMissionMississippiNational Comprehensive Cancer NetworkNational Human Genome Research InstituteNeoplasm MetastasisNorth CarolinaNursesParticipantPatientsPrognosisProstate Cancer therapyProstatectomyPublic HealthRaceRadiationRecommendationRecurrenceResearchRiskRuralRural PopulationSouth CarolinaStructureTechnologyTimeTissuesTrainingTreatment outcomeUnited StatesUnited States National Institutes of HealthVirginiacancer educationcancer health disparitycommunity engaged researchdesigndirected attentionefficacy evaluationevidence based guidelinesgenetic technologygenetic testinggenome scienceshealth disparityhealth literacyimprovedinnovationliteracylow health literacylow socioeconomic statusmRNA Expressionmathematical abilitymenmortalitynext generation sequencingnovelnovel strategiesoncotypeprognosticprognostic valueprogramsrandomized, controlled studyskillstheoriestreatment planning
No Sub Projects information available for 5K01CA230193-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K01CA230193-05
Patents
No Patents information available for 5K01CA230193-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K01CA230193-05
Clinical Studies
No Clinical Studies information available for 5K01CA230193-05
News and More
Related News Releases
No news release information available for 5K01CA230193-05
History
No Historical information available for 5K01CA230193-05
Similar Projects
No Similar Projects information available for 5K01CA230193-05